|
RFX5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.565800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.332190E-02 |
| Normal-vs-Stage2 |
4.266000E-01 |
| Normal-vs-Stage3 |
7.092400E-01 |
| Normal-vs-Stage4 |
8.613800E-02 |
| Stage1-vs-Stage2 |
4.101000E-01 |
| Stage1-vs-Stage3 |
2.347000E-01 |
| Stage1-vs-Stage4 |
3.494800E-01 |
| Stage2-vs-Stage3 |
8.385400E-01 |
| Stage2-vs-Stage4 |
1.758220E-01 |
| Stage3-vs-Stage4 |
2.119800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.276000E-02 |
| Normal-vs-AfricanAmerican |
1.095770E-01 |
| Normal-vs-Asian |
6.058100E-02 |
| Caucasian-vs-AfricanAmerican |
9.259200E-01 |
| Caucasian-vs-Asian |
4.828600E-01 |
| AfricanAmerican-vs-Asian |
4.313800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.007500E-02 |
| Normal-vs-Female |
8.910000E-01 |
| Male-vs-Female |
4.312400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.415800E-02 |
| Normal-vs-Extreme_Weight |
2.259900E-03 |
| Normal-vs-Obese |
2.109400E-01 |
| Normal-vs-Extreme_Obese |
9.101800E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.717800E-01 |
| Normal_Weight-vs-Obese |
4.510800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.820600E-01 |
| Extreme_Weight-vs-Obese |
1.076770E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.683400E-01 |
| Obese-vs-Extreme_Obese |
5.327600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.610000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.146000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.267600E-02 |
| Normal-vs-Age(81-100Yrs) |
2.317100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.584400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.763600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.379850E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.643400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.161700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.919900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.016800E-03 |
| Normal-VS-Type2 PRCC |
7.151200E-01 |
| Normal-VS-KIRP CIMP |
1.448970E-01 |
| Normal-VS-Unclassified PRCC |
2.798600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.634100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
6.504600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.438550E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.840400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.323400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.478200E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.247970E-02 |
| Normal-vs-N1 |
9.649800E-01 |
| Normal-vs-N2 |
6.488200E-01 |
| N0-vs-N1 |
2.728400E-01 |
| N0-vs-N2 |
7.988400E-01 |
| N1-vs-N2 |
7.481600E-01 |
|
|
